Global Pertussis Vaccine Market Outlook to 2023 Minhai Biotechnology, Beijing Tiantan, Biological Products, Astellas Pharma, Biological Products, Sanofi Pasteur, Mitsubishi Tanabe Pharma
(EMAILWIRE.COM, August 08, 2018 ) The Pertussis Vaccine market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the Pertussis Vaccine industrial chain, this report mainly elaborate the...
Subscribe to LegalLaw247.Com Newsletter